Engineering of Sialylated Mucin-type O-Glycosylation in Plants

Background: Plants lack the machinery for mucin-type O-glycosylation. Results: Transient expression of the mammalian O-glycosylation pathway in Nicotiana benthamiana resulted in the formation of sialylated mucin-type O-glycans on recombinant erythropoietin. Conclusion: Therapeutic proteins with engineered N- and O-glycosylation can be produced in plants. Significance: Plants are attractive hosts for the production of glycosylated recombinant proteins with defined glycan structures. Proper N- and O-glycosylation of recombinant proteins is important for their biological function. Although the N-glycan processing pathway of different expression hosts has been successfully modified in the past, comparatively little attention has been paid to the generation of customized O-linked glycans. Plants are attractive hosts for engineering of O-glycosylation steps, as they contain no endogenous glycosyltransferases that perform mammalian-type Ser/Thr glycosylation and could interfere with the production of defined O-glycans. Here, we produced mucin-type O-GalNAc and core 1 O-linked glycan structures on recombinant human erythropoietin fused to an IgG heavy chain fragment (EPO-Fc) by transient expression in Nicotiana benthamiana plants. Furthermore, for the generation of sialylated core 1 structures constructs encoding human polypeptide:N-acetylgalactosaminyltransferase 2, Drosophila melanogaster core 1 β1,3-galactosyltransferase, human α2,3-sialyltransferase, and Mus musculus α2,6-sialyltransferase were transiently co-expressed in N. benthamiana together with EPO-Fc and the machinery for sialylation of N-glycans. The formation of significant amounts of mono- and disialylated O-linked glycans was confirmed by liquid chromatography-electrospray ionization-mass spectrometry. Analysis of the three EPO glycopeptides carrying N-glycans revealed the presence of biantennary structures with terminal sialic acid residues. Our data demonstrate that N. benthamiana plants are amenable to engineering of the O-glycosylation pathway and can produce well defined human-type O- and N-linked glycans on recombinant therapeutics.

[1]  J W Fisher,et al.  Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. , 1988, The Journal of biological chemistry.

[2]  A. Varki,et al.  Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation , 2012, Biotechnology & genetic engineering reviews.

[3]  R. Zeleny,et al.  Sialic acid concentrations in plants are in the range of inadvertent contamination , 2006, Planta.

[4]  R. Cummings,et al.  The Tn Antigen—Structural Simplicity and Biological Complexity , 2011, Angewandte Chemie.

[5]  F. Altmann,et al.  Enzymatic Properties and Subcellular Localization of Arabidopsis β-N-Acetylhexosaminidases1[W][OA] , 2007, Plant Physiology.

[6]  H. Wandall,et al.  Mining the O-glycoproteome using zinc-finger nuclease–glycoengineered SimpleCell lines , 2011, Nature Methods.

[7]  J. Egrie,et al.  Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. , 2003, Experimental hematology.

[8]  A. Dell,et al.  Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. , 1987, The Journal of biological chemistry.

[9]  M. Krieger,et al.  The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. , 1991, Blood.

[10]  A. Kuno,et al.  Engineering of mucin-type human glycoproteins in yeast cells , 2008, Proceedings of the National Academy of Sciences.

[11]  Renate Kunert,et al.  Analysis of immunoglobulin glycosylation by LC‐ESI‐MS of glycopeptides and oligosaccharides , 2008, Proteomics.

[12]  A. Karnoup,et al.  O-linked glycosylation in maize-expressed human IgA1. , 2005, Glycobiology.

[13]  G. Stiegler,et al.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. , 2008, Plant biotechnology journal.

[14]  N. Borth,et al.  Growth, productivity and protein glycosylation in a CHO EpoFc producer cell line adapted to glutamine-free growth. , 2012, Journal of biotechnology.

[15]  M. Fukuda,et al.  Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. , 1989, Blood.

[16]  F. Altmann,et al.  N-Glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans , 2011, Glycobiology.

[17]  Z. Cichacz,et al.  Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins - towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation , 2010, BMC biotechnology.

[18]  Dirk Inzé,et al.  GATEWAY vectors for Agrobacterium-mediated plant transformation. , 2002, Trends in plant science.

[19]  Seung-Yeol Park,et al.  Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes. , 2011, Glycobiology.

[20]  S. Marillonnet,et al.  Systemic Agrobacterium tumefaciens–mediated transfection of viral replicons for efficient transient expression in plants , 2005, Nature Biotechnology.

[21]  Renate Kunert,et al.  In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway , 2010, The Journal of Biological Chemistry.

[22]  M. Bryckaert,et al.  In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor , 2012, PloS one.

[23]  K. Matsuoka,et al.  Reduction of Plant-Specific Arabinogalactan-Type O-Glycosylation by Treating Tobacco Plants with Ferrous Chelator 2,2′-Dipyridyl , 2011, Bioscience, biotechnology, and biochemistry.

[24]  T. Boone,et al.  Role of glycosylation on the secretion and biological activity of erythropoietin. , 1992, Biochemistry.

[25]  S. Masuda,et al.  The role of carbohydrate in recombinant human erythropoietin. , 1990, European journal of biochemistry.

[26]  R. Cummings,et al.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Henrik Clausen,et al.  Mucin-type O-glycosylation and its potential use in drug and vaccine development. , 2008, Biochimica et biophysica acta.

[28]  Daniel Kolarich,et al.  Determination of site-specific glycan heterogeneity on glycoproteins , 2012, Nature Protocols.

[29]  S. Elliott,et al.  Control of rHuEPO biological activity: the role of carbohydrate. , 2004, Experimental hematology.

[30]  A. Mehta,et al.  Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. , 2011, Blood.

[31]  M. Rodriguez-Franco,et al.  High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant. , 2007, Plant biotechnology journal.

[32]  F. Altmann,et al.  Construction of a Functional CMP-Sialic Acid Biosynthesis Pathway in Arabidopsis1[OA] , 2008, Plant Physiology.

[33]  R. Van Ree,et al.  Two Novel Types of O-Glycans on the Mugwort Pollen Allergen Art v 1 and Their Role in Antibody Binding* , 2005, Journal of Biological Chemistry.

[34]  A. Maxmen.  Drug-making plant blooms , 2012, Nature.

[35]  E. Bennett,et al.  Engineering Mammalian Mucin-type O-Glycosylation in Plants* , 2012, The Journal of Biological Chemistry.

[36]  R. Dwek,et al.  The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* , 1998, The Journal of Biological Chemistry.

[37]  E. Bennett,et al.  Toward Stable Genetic Engineering of Human O-Glycosylation in Plants1[C][W][OA] , 2012, Plant Physiology.

[38]  J. Tavernier,et al.  Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. , 2012, Journal of biotechnology.

[39]  T. Tzfira,et al.  A versatile vector system for multiple gene expression in plants. , 2005, Trends in plant science.

[40]  J. Vliegenthart,et al.  Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N-acetyllactosamine units. , 1995, European journal of biochemistry.

[41]  R. L. Harrison,et al.  Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins. , 2006, Advances in virus research.

[42]  R. Jefferis.  Isotype and glycoform selection for antibody therapeutics. , 2012, Archives of biochemistry and biophysics.

[43]  M. Rodriguez-Franco,et al.  High‐level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Δ‐fuc‐t Δ‐xyl‐t mutant , 2007 .

[44]  M. L. Alvarez,et al.  Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. , 2011, Plant biotechnology journal.

[45]  W. Reutter,et al.  Enhanced sialylation of EPO by overexpression of UDP‐GlcNAc 2‐epimerase/ManAc kinase containing a sialuria mutation in CHO cells , 2007, FEBS letters.

[46]  Roland Contreras,et al.  Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology , 2008, Nature Protocols.

[47]  Jack Hoopes,et al.  Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins , 2006, Science.

[48]  A. Bacic,et al.  O-Glycosylated Cell Wall Proteins Are Essential in Root Hair Growth , 2011, Science.

[49]  M. Tsujimoto,et al.  Role of sugar chains in the in-vitro activity of recombinant human interleukin 5. , 1993, European journal of biochemistry.

[50]  H. Steinkellner,et al.  IgG-Fc glycoengineering in non-mammalian expression hosts , 2012, Archives of biochemistry and biophysics.